BioSpace News Archive

Tissue and bone adhesives are crucial additions to normal methods of musculoskeletal tissue repair

Multi-year strategic collaboration in target discovery and therapeutic development based on Scenic Biotech’s disease modifying approach

Fennec Pharmaceuticals Inc. announced that the U.S. Patent and Trademark Office will issue U.S. Patent 10,792,363 entitled “Anhydrous Sodium Thiosulfate and Formulations Thereof.”

Axonics Modulation Technologies, Inc., a medical technology company that has developed and is commercializing novel implantable sacral neuromodulation devices for the treatment of urinary and bowel dysfunction, announced that Health Canada has approved its next generation rechargeable implantable neurostimulator for the Axonics r-SNM® System.

The global gynecological devices market is treading a growth path on the back of rising incidence of gynecological disorders such as fibroids and cervical cancer.

EASD, the leading European association in the field of diabetes, has selected the positive results of the international Phase II clinical study on TOTUM-63 in prediabetes to be presented next September in its 56th annual meeting. These results were selected by the American Diabetes Association last June 2020.

Inflazome is a pioneering inflammasome company developing orally available NLRP3 inflammasome inhibitors to address clinical unmet needs across a wide variety of inflammatory diseases

Updated guidelines represent a significant milestone in the adoption of Itamar’s Peripheral Arterial Tonometry (PAT) based Home Sleep Apnea Testing (HSAT) in Europe, following adoption in the UK, Holland, and Sweden

AdaptHealth Corp., a leading provider of home medical equipment, supplies and related services in the United States, announced the appointment of Frank J. Mullen as Chief Accounting Officer, a newly created position.

Portfolio Now Includes Ultra-Low Temperature Solutions to Meet Emerging Needs of Pharmaceutical Customers